未登录 分享 收藏
Identifying Clinical Characteristics of Hypoparathyroidism in Turkey: HIPOPARATURK-NET Study Degertekin, Ceyla Konca; Yavuz, Dilek Gogas; Pekkolay, Zafer; Saygili, Emre; Ugur, Kader; Koca, Arzu Or; Unubol, Mustafa; Topaloglu, Omercan; Aydogan, Berna Imge; Kutbay, Nilufer Ozdemir; Hekimsoy, Zeliha; Yilmaz, Nusret; Balci, Mustafa Kemal; Tanrikulu, Seher; Unsal, Yasemin Aydogan; Ersoy, Canan; Omma, Tulay; Keskin, Muge; Yalcin, Mehmet Muhittin; Yetkin, Ilhan; Soylu, Hikmet; Karakose, Melia; Yilmaz, Merve; Karakilic, Ersen; Piskinpasa, Hamide; Batman, Adnan; Akbaba, Gulhan; Elbuken, Gulsah; Bahadir, Cigdem Tura; Kilinc, Faruk; Bilginer, Muhammet Cuneyt; Iyidir, Ozlem Turhan; Canturk, Zeynep; Yilmaz, Banu Aktas; Sayiner, Zeynel Abidin; Eroglu, Mustafa 分享 收藏
分享 收藏
分享 收藏
BLOOD LIPIDS, DIABETIC COMPLICATIONS AND THE PHYSICIAN ATTITUDES ON DYSLIPIDEMIA TREATMENT; DATA FROM THE TURKISH NATIONWIDE SURVEY OF GLYCEMIC AND OTHER METABOLIC PARAMETERS OF PATIENTS WITH DIABETES Bayram, F.; Sonmez, A.; Haymana, C.; Sabuncu, T.; Dizdar, O. S.; Gurkan, E.; Carlioglu, A. Kargili; Agbaht, K.; Ozdemir, D.; Bicer, B. Kucuk; Barcin, C.; Salman, S.; Tetiker, T.; Balci, M. K.; Kebapci, N.; Ersoy, C.; Yumuk, V.; Satman, I. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy 在基础推注胰岛素治疗的晚期2型糖尿病患者中,德谷胰岛素可改善长期血糖控制,类似于甘精胰岛素,但低血糖发作较少 Hollander, P.; King, A. B.; Del Prato, S.; Sreenan, S.; Balci, M. K.; Munoz-Torres, M.; Rosenstock, J.; Hansen, C. T.; Niemeyer, M.; Garber, A. J. 分享 收藏
Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients:: Turkmen study Erdogan, MF; Gürsoy, A; Özgen, G; Çakir, M; Bayram, F; Ersoy, R; Algün, E; Çetinarslan, B; Çömlekçi, A; Kadioglu, P; Balci, MK; Yetkin, I; Kabalak, T; Erdogan, G 分享 收藏
分享 收藏
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial Garber, Alan J.; King, Allen B.; Del Prato, Stefano; Sreenan, Seamus; Balci, Mustafa K.; Munoz-Torres, Manuel; Rosenstock, Julio; Endahl, Lars A.; Francisco, Ann Marie Ocampo; Hollander, Priscilla 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏